| 51 |
22778941 | Mechanisms of Cisplatin-Induced Apoptosis and of Cisplatin Sensitivity: Potential of BIN1 to Act as a Potent Predictor of Cisplatin Sensitivity in Gastric Cancer Treatment. | 2012 |
1 |
| 52 |
23225459 | Expression analysis of iPS cell - inductive genes in esophageal squamous cell carcinoma by tissue microarray. | 2012 Dec |
1 |
| 53 |
21324178 | c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. | 2011 Feb 16 |
2 |
| 54 |
21447800 | c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance. | 2011 Mar 29 |
4 |
| 55 |
20008890 | c-MYC depletion potentiates cisplatin-induced apoptosis in head and neck squamous cell carcinoma: involvement of TSP-1 up-regulation. | 2010 Mar |
1 |
| 56 |
20459793 | Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc. | 2010 May 11 |
3 |
| 57 |
20890087 | Suppression of Aurora-A oncogenic potential by c-Myc downregulation. | 2010 Nov 30 |
1 |
| 58 |
19054066 | Platination of telomeric sequences and nuclease hypersensitive elements of human c-myc and PDGF-A promoters and their ability to form G-quadruplexes. | 2009 Jan |
1 |
| 59 |
19134217 | RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. | 2009 Jan 10 |
1 |
| 60 |
19996588 | Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines. | 2009 |
4 |
| 61 |
18375382 | c-Myc and caspase-2 are involved in activating Bax during cytotoxic drug-induced apoptosis. | 2008 May 23 |
1 |
| 62 |
17473215 | c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells. | 2007 May 1 |
8 |
| 63 |
17628013 | Gamma-glutamylcysteine synthetase mediates the c-Myc-dependent response to antineoplastic agents in melanoma cells. | 2007 Oct |
4 |
| 64 |
16466985 | Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin. | 2006 Feb |
4 |
| 65 |
16681749 | Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cells. | 2006 Mar-Apr |
1 |
| 66 |
16788862 | Downregulation of the PI3K/Akt survival pathway in cells with deregulated expression of c-Myc. | 2006 Aug |
1 |
| 67 |
15720258 | Cisplatin resistance and transcription factors. | 2005 Jan |
1 |
| 68 |
16083584 | [Adenovirus mediated antisense c-myc gene on the chemotherapy sensitivity of osteosarcoma cells to cisplatin]. | 2005 Jun 15 |
6 |
| 69 |
15153331 | Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agents. | 2004 May-Jun |
2 |
| 70 |
12080043 | p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression. | 2002 Aug 30 |
1 |
| 71 |
12123658 | Quantitation of gene-specific DNA damage by competitive PCR. | 2002 Jul 15 |
1 |
| 72 |
12435808 | c-Myc exerts a protective function through ornithine decarboxylase against cellular insults. | 2002 Dec |
2 |
| 73 |
11408612 | c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells. | 2001 Jul |
7 |
| 74 |
11707650 | Modification of the sensitivity to cisplatin with c-myc over-expression or down-regulation in colon cancer cells. | 2001 Nov |
7 |
| 75 |
10499637 | Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin. | 1999 Sep |
3 |
| 76 |
9443406 | c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice. | 1998 Jan 15 |
3 |
| 77 |
9389570 | Effects of an inducible anti-sense c-myc gene transfer in a drug-resistant human small-cell-lung-carcinoma cell line. | 1997 Nov 14 |
4 |
| 78 |
8712728 | Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines. | 1996 Jul-Aug |
1 |
| 79 |
8760592 | Sensitivity to cis-diamminedichloroplatinum in human cancer cells is related to expression of cyclin D1 but not c-raf-1 protein. | 1996 Jul 17 |
1 |
| 80 |
8862010 | Induction of MRP/GS-X pump and cellular resistance to anticancer prostaglandins. | 1996 |
1 |
| 81 |
7827130 | Relationships between proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells. | 1995 Jan 25 |
1 |
| 82 |
7923012 | Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide. | 1994 Nov 1 |
11 |
| 83 |
7694127 | Resistance of human larynx carcinoma cells to cisplatin, gamma-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenes. | 1993 Nov |
1 |
| 84 |
1806037 | The effect of cisplatin and carboplatin on c-myc promoter in erythroleukemic cells. | 1991 Dec |
3 |
| 85 |
1888169 | Cis-platin responsive sequences in the human c-myc promoter. | 1991 May-Jun |
2 |
| 86 |
2009531 | Modulation of cis-platinum resistance in Friend erythroleukemia cells by c-myc. | 1991 Apr 15 |
15 |
| 87 |
2064352 | Coordinate change of c-myc, transferrin receptor and H3 gene expression precedes induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II). | 1991 Mar-Apr |
2 |
| 88 |
2113532 | Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells. | 1990 Jul 5 |
1 |